Clinical Trials for Renal Cell Carcinoma

Find clinical trials for renal cell carcinoma. Discover research opportunities and treatment options in your area.

126 Active Trials Found

Showing 126 trials on this page

Page 6 of 7

Pucotenlimab Combined With Lenvatinib as a Neodjuvant Therapy for Non Clear Cell Renal Cell Carcinoma

NCT ID: NCT06129955

This clinical trial is studying a combination of two medications, Pucotenlimab and Lenvatinib, to see if they can help patients with a specific type of kidney cancer called non-clear cell renal cel...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China

A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

NCT ID: NCT06010875

This clinical trial is investigating a new treatment approach using a special type of immune cell therapy called CAR-T cells that target a protein called CD70. The goal is to see how safe and effec...

Recruiting

Phase: PHASE1 Type: interventional Locations: Nanchang, Jiangxi, China

Delving Into Participation Trends in Renal Cell Carcinoma Studies

NCT ID: NCT06093568

This clinical trial is focused on understanding the experiences of patients diagnosed with renal cell carcinoma, a type of kidney cancer, who are participating in a different clinical study that in...

Not yet recruiting

Type: observational Locations: San Francisco, California, United States

A Study of HS-10516 in Patients With Advanced Clear Cell Renal Cell Carcinoma

NCT ID: NCT06049030

This clinical trial is studying a new treatment called HS-10516 for patients with advanced clear cell renal cell carcinoma, which is a type of kidney cancer. The first part of the study aims to fin...

Not yet recruiting

Phase: PHASE1 Type: interventional

Multimodal Recurrence Scoring System for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment

NCT ID: NCT06032728

This clinical trial is studying a new way to determine which patients with stage III clear cell renal cell carcinoma (a type of kidney cancer) might benefit from additional targeted therapy after s...

Not yet recruiting

Phase: NA Type: interventional

Vascular Toxicities of Immune ChecKpoint Inhibitors : From Bed to Benchside

NCT ID: NCT06020651

The VICKI study is researching how immune checkpoint inhibitors (ICIs), a type of cancer treatment, might affect the heart and blood vessels in patients with certain cancers like renal cell carcino...

Recruiting

Phase: NA Type: interventional Locations: Paris, , France

Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes

NCT ID: NCT05534854

This clinical trial is focused on studying heritable kidney cancer syndromes, which are types of kidney cancer that can run in families due to genetic factors. Researchers want to understand how co...

Recruiting

Type: observational Locations: Shanghai, Shanghai, China

A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T

NCT ID: NCT05468190

This clinical trial is studying a new treatment approach for patients with certain types of advanced or metastatic solid tumors, including renal cell carcinoma, ovarian cancer, and cervical cancer....

Recruiting

Phase: PHASE1 Type: interventional Locations: Zhengzhou, Henan, China

Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer

NCT ID: NCT05420519

This clinical trial is studying a new treatment called CD70-targeted CAR-T therapy for patients with advanced renal cell carcinoma, a type of kidney cancer that has spread to other parts of the bod...

Recruiting

Phase: PHASE1 Type: interventional Locations: Jinan, Shandong, China

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

NCT ID: NCT05420545

This clinical trial is studying a new treatment called CD70-targeted CAR-T therapy for patients with advanced or metastatic solid tumors that express a protein called CD70. This includes cancers su...

Recruiting

Phase: PHASE1 Type: interventional Locations: Jinan, Shandong, China

The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery

NCT ID: NCT05739812

This clinical trial is studying a new surgical robot system called "MicroHand S" that allows doctors to perform surgeries for urinary system conditions from a distance. This means that even if pati...

Recruiting

Phase: NA Type: interventional Locations: Qingdao, Shandong, China

Primary Metastatic Renal Cell Carcinoma Treated With Immunecheckpoint Inhibitors and Cytoreductive Nephrectomy

NCT ID: NCT05941169

This clinical trial is studying a new approach to treating patients with advanced kidney cancer, specifically types known as renal cell carcinoma. The researchers want to see how effective a combin...

Not yet recruiting

Phase: NA Type: interventional

Drug Screening Using Novel IMD in Renal Cell Carcinoma

NCT ID: NCT05700461

This clinical trial is studying a new way to test the effectiveness of cancer drugs for patients with metastatic renal cell carcinoma (a type of kidney cancer that has spread to other parts of the ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States

Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity

NCT ID: NCT04631731

The ICEMELT study is a clinical trial designed to understand the risk factors that may cause side effects in patients receiving immune checkpoint inhibitors (ICIs) for certain types of cancer, incl...

Recruiting

Phase: PHASE1 Type: interventional Locations: Sydney, New South Wales, Australia, Sydney, New South Wales, Australia

Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma

NCT ID: NCT05738694

This clinical trial is studying a new treatment approach for patients with renal cell carcinoma (a type of kidney cancer) who are at high risk of their cancer coming back after surgery. The trial i...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, , China, Guangzhou, Guangdong, China +6 more

A Study of BPI-452080 in Subjects With Solid Tumors

NCT ID: NCT05843305

This clinical trial is studying a new treatment called BPI-452080 for patients with solid tumors, including specific types of kidney cancer. It is a Phase 1 study, which means it is one of the earl...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Chengdu, , China, Hangzhou, , China +6 more

Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer

NCT ID: NCT05285579

This clinical trial is exploring how certain biological markers in the body can help predict how well patients with advanced or metastatic kidney cancer will respond to a combination of treatments....

Recruiting

Type: observational Locations: Paris, , France, Paris, , France

Evaluation of the Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Advanced Renal Cell Carcinoma

NCT ID: NCT05798455

This clinical trial is looking at a new treatment called sodium pentaborate pentahydrate for patients with advanced renal cell carcinoma (RCC), a type of kidney cancer that has spread and cannot be...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Tabriz, East Azarbayejan, Iran, Islamic Republic Of

Biomarkers of Renal Cancer

NCT ID: NCT05785052

This clinical trial, titled "Biomarkers of Renal Cancer," is studying a new testing method to help doctors better understand and diagnose different types of kidney cancers. Researchers want to iden...

Recruiting

Type: observational Locations: Firenze, , Italy, Milano, , Italy +2 more

Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy

NCT ID: NCT04892849

This clinical trial, called STICI-02, is looking at how well a combination of certain cancer treatments works when used together. Specifically, it focuses on using PD-1/PD-L1 inhibitors, which are ...

Recruiting

Type: observational Locations: Erlangen, Bavaria, Germany

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions